Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma

MC Garin, KB Highland, RM Silver… - The Journal of …, 2009 - jrheum.org
Objective. To determine factors that influence 6-minute walk distance (6MWD) in patients
with scleroderma (systemic sclerosis, SSc)-interstitial lung disease (ILD), SSc-pulmonary …

The human experience with ghrelin administration

MC Garin, CM Burns, S Kaul… - The Journal of Clinical …, 2013 - academic.oup.com
Context: Ghrelin is an endogenous stimulator of GH and is implicated in a number of physiological
processes. Clinical trials have been performed in a variety of patient populations, but …

Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study

MC Garin, AM Arnold, JS Lee, J Robbins… - The Journal of …, 2014 - academic.oup.com
Background: Subclinical thyroid dysfunction is common in the elderly, yet its relationship
with hip fracture and bone mineral density (BMD) is unclear. Objective: We examined the …

Subclinical hypothyroidism, weight change, and body composition in the elderly: the Cardiovascular Health Study

MC Garin, AM Arnold, JS Lee, RP Tracy… - The Journal of …, 2014 - academic.oup.com
Background: Subclinical hypothyroidism is common in the elderly, yet its relationship with
weight and body composition is unclear. Objective: We examined the relationship between …

The spectrum of scleroderma lung disease

KB Highland, MC Garin… - Seminars in respiratory and …, 2007 - thieme-connect.com
Pulmonary disease is the most common cause of death in patients with systemic sclerosis.
This article discusses the variety of ways the lung is affected in systemic sclerosis. These …

Cost-utility of treatments for pulmonary arterial hypertension: a Markov state-transition decision analysis model

MC Garin, L Clark, ECG Chumney, KN Simpson… - Clinical drug …, 2009 - Springer
Background and Objective: Clinicians must choose between an increasing number of
medications for the treatment of pulmonary arterial hypertension (PAH) with different routes of …

Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome

MC Garin, SF Butts, DB Sarwer, KC Allison, S Senapati… - Endocrine, 2017 - Springer
Ghrelin is an endogenous appetite stimulant that may have a role in ovarian function. Women
with polycystic ovary syndrome have anovulation and frequently weight management …

Cost-utility of treatments for pulmonary arterial hypertension

MC Garin, EC Chumney, KN Simpson, KB Highland - Chest, 2007 - journal.chestnet.org
PURPOSE: New therapies for pulmonary arterial hypertension (PAH) improve functional
status, quality of life, and survival. Clinicians must now choose between an increasing number …

[HTML][HTML] Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts

J Corren, S Weinstein, L Janka, J Zangrilli, M Garin - Chest, 2016 - Elsevier
… Ms Janka and Dr Garin are employees of Teva and have shareholdings in Teva. Dr
Zangrilli is an employee of Teva, and has a patent pending for the use of reslizumab to treat …

[HTML][HTML] Long-term safety and efficacy of reslizumab in patients with eosinophilic asthma

…, L Bjermer, JM Fahrenholz, Y Shalit, M Garin… - The Journal of Allergy …, 2017 - Elsevier
Background In placebo-controlled trials, reslizumab, an anti-IL-5 monoclonal antibody,
significantly reduced asthma exacerbations and improved lung function and asthma control in …